A decade of the Asian Rotavirus Surveillance Network: Achievements and future directions

Vaccine

Volumn 27, Issue SUPPL. 5, 2009, Pages F1-

  Nelson, E Anthony S ^a   Widdowson, Marc Alain ^b   Kilgore, Paul E ^c   Steele, Duncan ^d   Parashar, Umesh D ^b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^c International Vaccine Institute   (South Korea)

^d PATH   (United States)

Author keywords

Disease burden; Economic analysis; GAVI Alliance; GIVS; Rotavirus; Vaccines

Indexed keywords

ROTAVIRUS VACCINE;

ASIA; CHILDHOOD MORTALITY; DIARRHEA; DISEASE SURVEILLANCE; EDITORIAL; GENOTYPE; HEALTH PROGRAM; HUMAN; IMMUNIZATION; INFECTION CONTROL; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; ROTAVIRUS; VIRUS INFECTION;

EID: 71649101196     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.09.001     Document Type: Editorial

References (19)

1. World Health Organization. Generic Protocol for (i) Hospital-based Surveillance to Estimate the Burden of Rotavirus Gastroenteritis in Children and (ii) a Community-based Survey on Utilization of Health Care Services for Gastroenteritis in Children (2002), WHO Publication WHO/V&B/02.15
2. Glass R.I., Bresee J.S., Parashar U.D., Jiang B., and Gentsch J. The future of rotavirus vaccines: a major setback leads to new opportunities. Lancet 363 9420 (2004) 1547-1550
3. Nelson E.A., Bresee J.S., Parashar U.D., Widdowson M.A., and Glass R.I. Rotavirus epidemiology: the Asian Rotavirus Surveillance Network. Vaccine 26 26 (2008) 3192-3196
4. GAVI. GAVI Task Force for R&D: Rotavirus Vaccine Agenda Meeting fast-tracking rotavirus vaccine development and introduction in developing countries: preparing a global agenda. http://www.gavialliance.org/resources/project_agenda_update.doc. 14-15 May 2001, Geneva; 2001, p. 21 [cited 10 August 2009].
5. McCarthy M. Project seeks to "fast track" rotavirus vaccine. Lancet 361 9357 (2003) 582
6. Bresee J.S., Hummelman E., Nelson E.A., and Glass R.I. Rotavirus in Asia: the value of surveillance for informing decisions about the introduction of new vaccines. J Infect Dis 192 Suppl. 1 (2005) S1-S5
7. Glass R.I., Parashar U.D., Bresee J.S., Turcios R., Fischer T.K., Widdowson M.A., et al. Rotavirus vaccines: current prospects and future challenges. Lancet 368 9532 (2006) 323-332
8. World Health Organization. Estimated rotavirus deaths for children under 5 years of age: 2004, 527,000. Available at: http://www.who.int/immunization_monitoring/burden/rotavirus_estimates/en/index.html. Geneva: World Health Organization; 2006 [cited 9 August 2009].
9. Podewils L.J., Antil L., Hummelman E., Bresee J., Parashar U.D., and Rheingans R. Projected cost-effectiveness of rotavirus vaccination for children in Asia. J Infect Dis 192 Suppl. 1 (2005) S133-S145
10. Fischer T.K., Anh D.D., Antil L., Cat N.D., Kilgore P.E., Thiem V.D., et al. Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam. J Infect Dis 192 10 (2005) 1720-1726
11. Lee W.S., Poo M.I., and Nagaraj S. Estimates of economic burden of providing inpatient care in childhood rotavirus gastroenteritis from Malaysia. J Paediatric Child Hlth 43 12 (2007) 818-825
12. Ho A.M., Nelson E.A., and Walker D.G. Rotavirus vaccination for Hong Kong children: an economic evaluation from the Hong Kong Government perspective. Arch Dis Child 93 1 (2008) 52-58
13. Wu C.L., Yang Y.C., Huang L.M., and Chen K.T. Cost-effectiveness of childhood rotavirus vaccination in Taiwan. Vaccine 27 10 (2009) 1492-1499
14. Fu C., Wang M., Liang J., He T., Wang D., and Xu J. Effectiveness of Lanzhou lamb rotavirus vaccine against rotavirus gastroenteritis requiring hospitalization: a matched case-control study. Vaccine 25 52 (2007) 8756-8761
15. Barnes G. Vaccines for neonatal viral infections: rotavirus. Expert Rev Vaccines 3 4 (2004) 359-361
16. World Health Organization. Rotavirus vaccines. Wkly Epidemiol Rec 82 32 (2007) 285-295
17. Meeting of the immunization Strategic Advisory Group of Experts April 2009-conclusions and recommendations. Wkly Epidemiol Rec 84 23 (2009) 220-236
18. Cunliffe N.A., Kirsten M., Madhi S., Witte D., Ngwira B., Bos P., et al. Efficacy of human rotavirus vaccine RIUX4414 in Africa during the first year of life. 27th Annual Meeting of the European Society of Paediatric Infectious Diseases. Brussels, Belgium (2009)
19. Parashar U.D., and Glass R.I. Rotavirus vaccines-early success, remaining questions. N Engl J Med 360 11 (2009) 1063-1065